ALLO News and Press, Allogene Therapeutics Inc.

2026-03-17 09:38:03 ET After the great allogeneic stumble in 2021 , when the FDA slapped a clinical hold on Allogene's [ALLO] ALLO-501A, the entire allogeneic CAR-T sector was crushed. The stock was cut from $25/share to $13/share in a day and was eventually decimated to where it cu...

2026-03-13 02:22:53 ET More on Allogene Therapeutics Allogene Therapeutics, Inc. (ALLO) Q4 2025 Earnings Call Transcript Allogene Therapeutics, Inc. (ALLO) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript Allogene Therapeutics Q4 2025 Earnings Pr...

2026-03-13 02:22:22 ET Allogene Therapeutics, Inc. (ALLO) Q4 2025 Earnings Call March 12, 2026 5:00 PM EDT... Read the full article on Seeking Alpha For further details see: Allogene Therapeutics, Inc. (ALLO) Q4 2025 Earnings Call Transcript

2026-03-12 19:21:01 ET Image source: The Motley Fool. Thursday, March 12, 2026 at 5 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-03-12 16:03:44 ET More on Allogene Therapeutics Allogene Therapeutics, Inc. (ALLO) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript Allogene Therapeutics Q4 2025 Earnings Preview Allogene upgraded at Citizens on discounted EPS, revenue multi...

Pivotal, Randomized Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) Positions Company at the Forefront of MRD-Guided 1L Consolidation Treatment in Both Academic and Community Cancer Centers, and Advances a Broade...

2026-03-12 10:00:00 ET Major earnings expected after the bell on Thursday include: Adobe ( ADBE ) Wheaton Precious Metals Corp. ( WPM ) SentinelOne ( S ) Inovio Pharmaceuticals ( INO ) Ulta Beauty ( ULTA ) Read the full article on Seeking Al...

EHang Holdings Limited (EH) is expected to report $-0.06 for Q4 2025 McEwen Inc. (MUX) is expected to report $0.25 for Q4 2025 Hannover Ruck SE ADR - Level I (HVRRY) is expected to report $1.03 for Q4 2025 VAALCO Energy Inc. (EGY) is expected to report $0.02 for Q4 2025 Full Truck...

2026-03-11 17:30:42 ET More on Allogene Therapeutics Allogene Therapeutics, Inc. (ALLO) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript Allogene upgraded at Citizens on discounted EPS, revenue multiple Seeking Alpha’s Quant Rating on Allo...

Conference Call and Webcast Scheduled for March 12, 2026 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) p...